BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16115486)

  • 1. Combined monogenic hypercholesterolemia and hypoalphalipoproteinemia caused by mutations in LDL-R and LCAT genes.
    Pisciotta L; Calabresi L; Lupattelli G; Siepi D; Mannarino MR; Moleri E; Bellocchio A; Cantafora A; Tarugi P; Calandra S; Bertolini S
    Atherosclerosis; 2005 Sep; 182(1):153-9. PubMed ID: 16115486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel LCAT mutation (Phe382-->Val) in a kindred with familial LCAT deficiency and defective apolipoprotein B-100.
    Nanjee MN; Stocks J; Cooke CJ; Molhuizen HO; Marcovina S; Crook D; Kastelein JP; Miller NE
    Atherosclerosis; 2003 Sep; 170(1):105-13. PubMed ID: 12957688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetic study of Finns with hypoalphalipoproteinemia and hyperalphalipoproteinemia: a novel Gly230 Arg mutation (LCAT[Fin]) of lecithin:cholesterol acyltransferase (LCAT) accounts for 5% of cases with very low serum HDL cholesterol levels.
    Miettinen HE; Gylling H; Tenhunen J; Virtamo J; Jauhiainen M; Huttunen JK; Kantola I; Miettinen TA; Kontula K
    Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):591-8. PubMed ID: 9555865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel missense variants in LCAT and APOB genes in an Italian kindred with familial lecithin:cholesterol acyltransferase deficiency and hypobetalipoproteinemia.
    Conca P; Pileggi S; Simonelli S; Boer E; Boscutti G; Magnolo L; Tarugi P; Penco S; Franceschini G; Calabresi L; Gomaraschi M
    J Clin Lipidol; 2012; 6(3):244-50. PubMed ID: 22658148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and functional analysis of missense mutations in the lecithin cholesterol acyltransferase gene in a Chilean patient with hypoalphalipoproteinemia.
    Tobar HE; Cataldo LR; González T; Rodríguez R; Serrano V; Arteaga A; Álvarez-Mercado A; Lagos CF; Vicuña L; Miranda JP; Pereira A; Bravo C; Aguilera CM; Eyheramendy S; Uauy R; Martínez Á; Gil Á; Francone O; Rigotti A; Santos JL
    Lipids Health Dis; 2019 Jun; 18(1):132. PubMed ID: 31164121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families.
    Calabresi L; Pisciotta L; Costantin A; Frigerio I; Eberini I; Alessandrini P; Arca M; Bon GB; Boscutti G; Busnach G; Frascà G; Gesualdo L; Gigante M; Lupattelli G; Montali A; Pizzolitto S; Rabbone I; Rolleri M; Ruotolo G; Sampietro T; Sessa A; Vaudo G; Cantafora A; Veglia F; Calandra S; Bertolini S; Franceschini G
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1972-8. PubMed ID: 15994445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial lecithin-cholesterol acyltransferase deficiency: biochemical characteristics and molecular analysis of a new LCAT mutation in a Polish family.
    Idzior-Waluś B; Sieradzki J; Kostner G; Małecki MT; Klupa T; Wesołowska T; Rostworowski W; Hartwich J; Waluś M; Kieć AD; Naruszewicz M
    Atherosclerosis; 2006 Apr; 185(2):413-20. PubMed ID: 16051254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new molecular defect in the lecithin: cholesterol acyltransferase (LCAT) gene associated with fish eye disease.
    Contacos C; Sullivan DR; Rye KA; Funke H; Assmann G
    J Lipid Res; 1996 Jan; 37(1):35-44. PubMed ID: 8820100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction of hypoalphalipoproteinemia in LDL receptor-deficient rabbits by lecithin:cholesterol acyltransferase.
    Brousseau ME; Wang J; Demosky SJ; Vaisman BL; Talley GD; Santamarina-Fojo S; Brewer HB; Hoeg JM
    J Lipid Res; 1998 Aug; 39(8):1558-67. PubMed ID: 9717715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmission of two novel mutations in a pedigree with familial lecithin:cholesterol acyltransferase deficiency: structure-function relationships and studies in a compound heterozygous proband.
    Argyropoulos G; Jenkins A; Klein RL; Lyons T; Wagenhorst B; St Armand J; Marcovina SM; Albers JJ; Pritchard PH; Garvey WT
    J Lipid Res; 1998 Sep; 39(9):1870-6. PubMed ID: 9741700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two different allelic mutations in the lecithin-cholesterol acyltransferase gene associated with the fish eye syndrome. Lecithin-cholesterol acyltransferase (Thr123----Ile) and lecithin-cholesterol acyltransferase (Thr347----Met).
    Klein HG; Lohse P; Pritchard PH; Bojanovski D; Schmidt H; Brewer HB
    J Clin Invest; 1992 Feb; 89(2):499-506. PubMed ID: 1737840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial hypercholesterolemia associated with severe hypoalphalipoproteinemia in a Moroccan family.
    Ait Chihab K; Chater R; Cenarro A; Kettani A; Castillo S; Loutfi M; Ribalta J; Adlouni A; Pocovi M; El Messal M
    J Genet; 2007 Aug; 86(2):159-63. PubMed ID: 17968143
    [No Abstract]   [Full Text] [Related]  

  • 13. Classical LCAT deficiency resulting from a novel homozygous dinucleotide deletion in exon 4 of the human lecithin: cholesterol acyltransferase gene causing a frameshift and stop codon at residue 144.
    Teh EM; Chisholm JW; Dolphin PJ; Pouliquen Y; Savoldelli M; de Gennes JL; Benlian P
    Atherosclerosis; 1999 Sep; 146(1):141-51. PubMed ID: 10487497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of an exon 3 mutation (Trp66-->Gly) of the LDL receptor with variable expression of familial hypercholesterolemia in a French Canadian family.
    Levy E; Minnich A; Cacan SL; Thibault L; Giroux LM; Davignon J; Lambert M
    Biochem Mol Med; 1997 Feb; 60(1):59-69. PubMed ID: 9066982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ApoA-I(MALLORCA) impairs LCAT activation and induces dominant familial hypoalphalipoproteinemia.
    Martín-Campos JM; Julve J; Escolà JC; Ordóñez-Llanos J; Gómez J; Binimelis J; González-Sastre F; Blanco-Vaca F
    J Lipid Res; 2002 Jan; 43(1):115-23. PubMed ID: 11792730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel TC deletion resulting in Pro(260)-->Stop in the human LCAT gene is associated with a dominant effect on HDL-cholesterol.
    Kasid A; Rhyne J; Zeller K; Pritchard H; Miller M
    Atherosclerosis; 2001 May; 156(1):127-32. PubMed ID: 11369005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial lecithin:cholesterol acyltransferase deficiency: molecular analysis of a compound heterozygote: LCAT (Arg147 --> Trp) and LCAT (Tyr171 --> Stop).
    Guerin M; Dachet C; Goulinet S; Chevet D; Dolphin PJ; Chapman MJ; Rouis M
    Atherosclerosis; 1997 May; 131(1):85-95. PubMed ID: 9180249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two different allelic mutations in the lecithin:cholesterol acyltransferase (LCAT) gene resulting in classic LCAT deficiency: LCAT (tyr83-->stop) and LCAT (tyr156-->asn).
    Klein HG; Lohse P; Duverger N; Albers JJ; Rader DJ; Zech LA; Santamarina-Fojo S; Brewer HB
    J Lipid Res; 1993 Jan; 34(1):49-58. PubMed ID: 8445342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LCAT modulates atherogenic plasma lipoproteins and the extent of atherosclerosis only in the presence of normal LDL receptors in transgenic rabbits.
    Brousseau ME; Kauffman RD; Herderick EE; Demosky SJ; Evans W; Marcovina S; Santamarina-Fojo S; Brewer HB; Hoeg JM
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):450-8. PubMed ID: 10669643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete and Partial Lecithin:Cholesterol Acyltransferase Deficiency Is Differentially Associated With Atherosclerosis.
    Oldoni F; Baldassarre D; Castelnuovo S; Ossoli A; Amato M; van Capelleveen J; Hovingh GK; De Groot E; Bochem A; Simonelli S; Barbieri S; Veglia F; Franceschini G; Kuivenhoven JA; Holleboom AG; Calabresi L
    Circulation; 2018 Sep; 138(10):1000-1007. PubMed ID: 29748187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.